Core Viewpoint - Xiaofang Pharmaceutical (603207) experienced a significant increase of 6.23% in stock price, with a trading volume turnover rate of 31.10% and a total transaction value of 462 million yuan, indicating strong market interest and activity [2]. Trading Activity - The stock was listed on the Shanghai Stock Exchange due to its turnover rate reaching 31.10%, with institutional investors net buying 17.7364 million yuan [2]. - The top five trading departments accounted for a total transaction value of 110 million yuan, with a net buying amount of 3.9196 million yuan [2]. - Among the trading departments, one institutional special seat was noted as the top buyer, contributing a net purchase of 17.7364 million yuan [2]. Fund Flow - The stock saw a net inflow of 1.1686 million yuan in main funds, with large orders contributing a net inflow of 1.8799 million yuan, while large orders experienced a net outflow of 711,200 yuan [2]. - Over the past five days, the net inflow of main funds totaled 59.9802 million yuan [2]. Financial Performance - In the first quarter, Xiaofang Pharmaceutical reported a revenue of 129 million yuan, reflecting a year-on-year growth of 3.33%, and a net profit of 59.8427 million yuan, which is a year-on-year increase of 14.63% [2].
小方制药8月4日龙虎榜数据